Dapagliflozin in the Prevention of Post-Coronary Angioplasty Acute Kidney Injury
Status:
Not yet recruiting
Trial end date:
2023-07-01
Target enrollment:
Participant gender:
Summary
To compare the incidence of acute kidney injury (AKI) post percutaneous coronary intervention
(PCI) in a Dapagliflozin treated group versus a group managed with the standard of care.